{
  "trial_id": "NCT03207945",
  "overall_assessment": "likely_ineligible",
  "inclusion": [
    {
      "criterion": "Males and females equal or greater than 40 years of age.",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Documented HIV infection.",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "HIV-1 RNA level below 200 copies/mL for at least 12 weeks prior to study entry",
      "label": "unknown",
      "evidence": "quote"
    },
    {
      "criterion": "CD4 T Cells \u2265200 cells/mm3 at screening",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Continuous ART for at least 12 weeks with no change in regimen prior to study entry.",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Moderate or high CVD risk defined as: documented CVD as assessed by meeting at least 1 of 3 criteria below:",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Coronary artery disease (CAD)",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Cerebrovascular disease",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Peripheral arterial disease",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Controlled type II diabetes mellitus (HbA1C \u2264 8.0%)",
      "label": "unknown",
      "evidence": "quote"
    },
    {
      "criterion": "Family history: a first degree relative who had a heart attack, stroke, or documented CVD as defined in the previous section that occurred:",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Current smoking",
      "label": "unknown",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "Subjects who are investigational site staff members directly involved in the conduct of the trial and their family members, site staff members otherwise supervised by the Investigator, or subjects who are Regeneron employees.",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Participation in other studies involving small molecule investigational drug(s).",
      "label": "not_met",
      "evidence": "none"
    }
  ],
  "notes": "The patient has a history of CAD and severe stenosis in the left internal carotid artery, which may be a contraindication for the study. Additionally, the patient's LDL-C level is high (545 mg/dL), which may also be a contraindication.",
  "_meta": {
    "topic_id": "62",
    "trial_id": "NCT03207945",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}